FDA Issues Draft Guidance for 510(k) Third Party (TP) Review Program
Today, the U.S. Food and Drug Administration (FDA) released a draft guidance document entitled “510(k) Third Party Review Program.” The purpose of this draft guidance is to explain the FDA’s…